论文部分内容阅读
目的了解布地奈德福莫特罗粉吸入剂治疗哮喘的疗效。方法通过治疗前后肺功能、ACT评分的比较判定布地奈德福莫特罗粉吸入剂的疗效。结果哮喘患者使用布地奈德福莫特罗粉吸入剂后FEV1、FEEF25-75、ACT评分与治疗前相比差异有统计学意义(P<0.001)。结论布地奈德福莫特罗粉吸入剂可有效的改善哮喘患者的肺功能指标及症状,达到治疗目的。
Objective To investigate the efficacy of budesonide formoterol powder inhaler in the treatment of asthma. Methods The efficacy of budesonide formoterol powder inhaler was evaluated by comparison of pulmonary function and ACT score before and after treatment. Results The FEV1, FEEF25-75, ACT scores of asthma patients after using budesonide formoterol powder inhalation powder were significantly different from those before treatment (P <0.001). Conclusions Budesonide formoterol powder inhaler can effectively improve the lung function indexes and symptoms of asthmatic patients and achieve the therapeutic goal.